Summary. The plasma concentration, production rate, and conversion ratio of androstenedione and testosterone were studied in seven children with congenital adrenal hyperplasia (CAH) of the 21-hydroxylase type. Plasma androstenedione and testosterone measured by double isotope derivative assay and estimated blood production rates were manyfold increased in the untreated state, markedly suppressed with glucocorticoid, and increased after the administration of ACTH.
Introduction
The major clinical manifestation in patients with congenital adrenal hyperplasia (CAH) of the 21-hydroxylase type is progressive virilization. These abnormalities can be reproduced by the administration of androgenic steroids. In this disorder, an enzyme deficiency in cortisol synthesis and secretion leads to hypersecretion of adreno-corticotropin (ACTH), which partially overcomes the block, but at the expense of increased secretion of steroid precursors among which are androgenic steroids (1) (2) (3) .
The nature of the androgenic substance responsible for the clinical manifestations of adrenal hyperplasia has not been clarified. Since testosterone is the most potent natural androgenic hormone and the adrenal is capable of synthesizing testosterone (4) , increased secretion of this steroid has been suggested as the responsible mechanism. This hypothesis is supported by the demonstration of increased urinary excretion (5) (6) (7) (8) (9) (10) (11) , plasma concentration (10, (12) (13) (14) , and production rate (10) (11) (12) (13) (14) (15) (16) (17) (18) (19) of testosterone in patients with congenital adrenal hyperplasia. However, recent work by Korenman and Lipsett (15) and Horton and Tait (16) indicates that the weak androgen, androstenedione (androst-4-ene-3, 17- ther demonstrated that almost two-thirds of blood testosterone in the normal female is derived from blood androstenedione. Since an analogous situation might be present in certain clinical states, this study was designed to further explore the in vivo mechanism of virilization in congenital adrenal hyperplasia.
Methods
Three prepubertal females and four prepubertal males with congenital adrenal hyperplasia were studied. Two children were previously untreated (R.D., F.D.), and five were studied 4 to 6 weeks after suppressive therapy had been discontinued. All patients were significantly virilized in the untreated state with advanced bone age. The diagnosis of congenital adrenal hyperplasia was based on progressive virilization, increased excretion of 17-ketosteroids and pregnanetriol, normal or low 17-hydroxysteroid excretion (Porter-Silber chromogens), and urinary ketosteroid suppression with physiological doses of cortisol or cortisol analogue. Therefore, all patients are considered to have a 21-hydroxylase block.
Urinary 17-ketosteroids were determined by a modification of the method of Drekter and associates (17) , and urinary pregnanetriol was measured by the technique of Cox (18) . Normal values for prepubertal children are less than 5 mg per day and less than 2 mg per day, respectively.
Plasma testosterone and androstenedione were measured by double isotope derivative techniques using thiosemicarbazide-5S and steroid-1,2-3H indicator of high specific activity. Testosterone was measured by the method of Riondel and co-workers (19) and androstenedione by the method of Horton (20) . The nonspecific blank, accuracy, and sensitivity are as originally described. Greater experience with these techniques has resulted in an equivalent or increased recovery with half the original amount of reagent used (0.5 mg, SA 140 to 160 mc per mmole). This improvement, however, has no bearing upon sensitivity and accuracy, which are primarily dependent upon the variation of the nonspecific blank (21) . The metabolic clearance rate of androstenedione and testosterone and their conversion ratios in blood were determined by constant infusion of tritiated steroid and isolation of infused steroid and its conversion product from plasma as previously described (16) . The infusions were all performed between 8 and 11 a.m. The metabolic clearance rate was calculated as the rate of infusion of 'H per day divided by the plasma radioactivity as the infused steroid per liter at equilibrium corrected for recovery. The blood production rate, which is the total amount of hormone entering the general circulation, was calculated as the product of the plasma concentration and the metabolic clearance rate (16) . A diurnal variation in plasma testosterone, although of lesser magnitude than cortisol, has been noted in normal adult male subjects (22) . Therefore the mean calculated testosterone blood production rate is an estimation of the actual daily blood production rate.
The conversion ratio in blood was calculated as previously described (16) as the ratio of counts per minute 'H per liter corrected for recovery, of product to precursor. Previous work has demonstrated that equilibrium is obtained in blood after infusion of 'H-labeled androstenedione and testosterone for 130 minutes and that the chromatographic systems result in radiochemical isolation of both these steroids from plasma (16) .
The recoveries, levels of counting, and counting errors of this approach are described in the original paper (16) and extensively discussed in a recent report by Horton and Tait (23) .
Results
Urinary steroids. The urinary steroid excretions of the children with CAH, in the untreated state and after cortisol suppression, are shown in Table I . The mean excretion of 17-ketosteroids and pregnanetriol in the untreated state was 17 mg per day. No sex differences in these values were noted in these children with CAH.
Treatment with cortisol resulted in a fall in the mean 17-ketosteroid value to 3.7 mg per day. In all subjects the ketosteroid values reached normal or subnormal levels on low doses of cortisol (20 to 30 mg per day).
Plasma concentration of androstenedione and testosterone in congenital adrenal hyperplasia. The mean concentration of androstenedione (corrected for the mean blank of 17 mjug per 100 ml) was 380 mptg per 100 ml for males and 647 mug per 100 ml for females with CAH. Mean plasma testosterone (corrected for the mean blank of 19 mjug per 100 ml) was 144 mnug per 100 ml for and testosterone-3H (Table III) .
t Amount of T in plasma unaccounted for by peripheral conversion of A. males and 137 m~Ltg per 100 ml for females with CAH ( Figure 1 and Table II) . Plasma concentrations in male children with congenital adrenal hyperplasia receiving cortisol were 26 mpzg per 100 ml androstenedione and 42 m/Ag per 100 ml testosterone, and in females were 43 mptg per 100 ml androstenedione and 2 mug per 100 ml (essentially undetectable) testosterone (Table II) .
Metabolic clearance rate (MCR). The metabolic clearance rate of androstenedione-3H (MCRA) in children with CAH is presented in Table III After cortisol suppression, the calculated blood production of androstenedione was less than 0.5 mg per day per in2 in all groups. Production rate in blood of testosterone after treatment was unmeasurable in female children and 0.21 mg per day per m2 in prepubertal male children with CAH.
Conversion ratios in blood in CAH. The conversion ratio of androstenedione to testosterone in blood (CRBBAT) in seven children with CAH was 15 + 0.6 (SE) % (Table II) . There was no sex difference in the children studied. The conversion rate in normal adults has been measured at 14+1 (SE) %o (16) .
The back conversion of testosterone to androstenedione was 3.4% and 1.0%o in two prepubertal CAH children. The CRBBTA in adults is 2.8 ± 0.2 (SE) %o (16) .
The contribution of plasma androstenedione to plasma testosterone in untreated congenital adrenal hyperplasia. The product of plasma androstenedione concentration and the conversion ratio (CRBBAT) yields the concentration of plasma testosterone derived from plasma androstenedione, and this with the total concentration of plasma testosterone in the same sample allows calculation of the per cent of plasma testosterone derived from plasma androstenedione from peripheral conversion. This calculation is simplified by the finding that the back conversion is insignificant in terms of actual contribution to androstenedione concentrations in blood. In the prepubertal females with CAH, 101 m/ug per 100 ml testosterone, and in the male, 54 mug per 100 ml testosterone was derived from the peripheral conversion of androstenedione. This is 76% and 36%o of total plasma testosterone in female and male children with untreated CAH, respectively (Table II) . The remaining amount of testosterone in plasma unaccounted for by peripheral conversion of androstenedione (T from "T," Table II) was 32 m,ug per 100 ml in the female and 89 mjug per 100 ml in the males with CAH.
The effect of ACTH on plasma androgens in CAH. To determine the effect of ACTH on the virilizing levels of plasma androgen, we gave .three prepubertal subjects (two males and one female), suppressed with cortisol for 4 weeks, iv infusions of ACTH, 25 U in 360 ml 5% dextrose in water for 6 hours. There was a rise in both plasma androstenedione and testosterone in all three subjects. In two, the final values were similar to those noted in the untreated 'state (Table IV) . In the third patient, R.S., a 10-year-old male treated for 7 years, there initially was only a minimal rise in plasma androgens after ACTH. He was then given ACTH gel, 40 U every 12 hours for 4 days followed by another iv ACTH -infusion. The con- Consideration of the markedly increased concentration of androstenedione and the conversion ratios indicates that about two-thirds of the testosterone in the female children with CAH and about one-third in the males are derived from peripheral conversion of blood androstenedione. The difference in the two sexes may be more apparent than real, since the remaining concentration of testosterone in plasma after subtraction of the androstenedione contribution (T from "T") is of the same order of magnitude as normal prepubertal values in the respective sexes (29) . The data suggest that almost all of the increased testosterone in plasma in children with CAH and virilization is the result of increased androstenedione secretion.
Camacho and Migeon have recently measured the excretion of testosterone glucuronoside and calculated the production rate from the integrated specific activity of the urinary metabolite (Tg) in patients with CAH. The excretion and calculated production rates are increased in CAH when compared with normal controls. The production rate of testosterone from the urinary metabolite in the single prepubertal female studied was 2.78 mg per day (11) . If this value and our studies are representative of the disorder before puberty, it can be calculated that about 2.4 mg of testosterone glucuronoside (Tg) should be derived from blood androstenedione using the over-all conversion of androstenedione to urinary testosterone of 40%o (23, 26) (6.3 mg androstenedione per day X 0.4 = 2.4 mg Tg per day). This would indicate that almost all of the testosterone production rate calculated from the urinary metabolite of testosterone is derived from blood androstenedione in CAH. This is further evidence that the direct secretion of blood testosterone in the female child with CAH is minimal.
The major role in CAH of androstenedione secreted by the adrenal cortex under the influence of ACTH appears to be established. Virilization arises from the marked increase in blood testosterone production resulting in large part from the peripheral conversion of abnormal amounts of the secreted precursor androstenedione.
